Clinical Trials Logo

Filter by:
NCT ID: NCT01048853 Active, not recruiting - Clinical trials for Cervical Adenocarcinoma

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

Start date: August 25, 2009
Phase: N/A
Study type: Interventional

This clinical trial studies conservative surgery in treating patients with low-risk stage IA2 or IB1 cervical cancer. Conservative surgery is a less invasive type of surgery for early stage cervical cancer and may have fewer side effects and improve recovery.

NCT ID: NCT01048138 Terminated - Clinical trials for Traumatic Brain Injury

Use of Biperiden for the Prevention of Post-traumatic Epilepsy

Start date: January 31, 2018
Phase: Phase 3
Study type: Interventional

There is no AED or medication that has been demonstrated to affect the development of post-traumatic epilepsy. Biperiden is a cholinergic antagonist, acting in the muscarinic receptor, that is widely used as an anti Parkinson drug. The investigators data with animal models of epilepsy indicate that anti-muscarinic agents might affect the natural course of the disease in the case of post-traumatic epilepsy.

NCT ID: NCT01047670 Recruiting - Clinical trials for Mechanical Ventilation

Septic Shock em Steroids

Start date: May 2008
Phase: Phase 2/Phase 3
Study type: Interventional

Septic shock is a frequent reason for admission on pediatric intensive care units. Interventions which can change morbidity and mortality of septic shock patients are of great interest. Steroid replacement in adults with severe sepsis and septic shock have been extensively studied. It was recently demonstrated that low dose steroid (< 300mg/ day) used for more than 5 days was associated with decreased mortality and lower requirement of vasoactive support in the adult population that had a low response to the ACTH test. However, this was not confirmed in the latest results from the CORTICUS study. Use of low dose hydrocortisone, or any other steroid has not been studied in critically ill children. Mortality associated with sepsis in children has decreased in the last decade and currently it is close to 10%, making it difficult to power a study able to show reduced mortality. Taking into account the results from previous studies reporting the high incidence of adrenal failure and its association to worse outcome, we have designed a clinical trial to evaluate the effect of low dose hydrocortisone in children with septic shock: Cortisol Replacement in Children with Sepsis Study.

NCT ID: NCT01047657 Completed - Obesity Clinical Trials

Effects of Weight Loss in Obese Difficult-to-treat Asthmatics

Start date: November 2009
Phase: Phase 3
Study type: Interventional

Sixty percent of patients with difficult to control asthma seen in our outpatient clinic are obese. The impact of weight reduction in this subpopulation of asthmatics has not been studied. Our aim is to evaluate the impact of weight reduction on asthma control of these patients.

NCT ID: NCT01046760 Active, not recruiting - Rolandic Epilepsy Clinical Trials

Scholar Performance and Praxis Assessment in Children With Rolandic Epilepsy

Start date: September 2009
Phase: N/A
Study type: Observational

Rolandic Epilepsy is the most common form of childhood epilepsy. It is classified as idiopathic, age-related epilepsy syndrome with benign evolution. The absence of neuropsychological impairment is part of the criteria of benignity of this epilepsy syndrome. However recently have been suggested several deficits related to attention and language. The purpose of this study was assess school performance and to investigate problems of praxis in patients with rolandic epilepsy as compared to a control group composed of normal children with age, gender and educational level equivalents.

NCT ID: NCT01046474 Completed - Physical Activity Clinical Trials

Reducing Beverages and Sugar and Increasing Physical Activity in Public School Adolescents From Brazil

PAPAS
Start date: February 2010
Phase: Phase 3
Study type: Interventional

The main objective is to evaluate the effect on BMI of a school-based program that discourages the consumption of all sweetened beverages, encourages the reduction in sugar intake, and encourages the increase in physical activity among adolescents and their families from a low socioeconomic area.

NCT ID: NCT01043913 Completed - Neoplasms Clinical Trials

Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue

Start date: February 2008
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that Guaraná, a native plant from the Amazon, might improve chemotherapy-induced fatigue in breast cancer patients undergoing treatment. In order to assess this, the investigators randomized patients to either guaraná extract or to placebo, switching the assigned treatment mid-term through the cycles of Chemotherapy.

NCT ID: NCT01043341 Completed - Behavior Clinical Trials

Knowledge and Attitude About HPV Vaccines

Start date: October 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study was to analyze the knowledge and attitude about HPV vaccines among Brazilian women after an educative intervention. The knowledge was measured on sexual behavior and HPV infection. The attitude was measured on acceptance of vaccines.

NCT ID: NCT01043328 Completed - Clinical trials for Squamous Cell Carcinoma

Human Papillomavirus on Oral Tissue, Saliva and Serum

CDHPOTSS
Start date: May 2009
Phase: N/A
Study type: Observational

Human papillomavirus (HPV) is one of the most prevalent infections in the world with several millions of new cases diagnosed yearly. Oral HPV infection may be associated with different diseases of oral cavities including some cases of oropharyngeal cancer. The aim of this report is to detect the presence of HPV DNA in samples of biopsies, oral swabs, saliva and serum of patient with oral squamous cell carcinoma (OSCC) and controls. We hoped to find there is correlation among the presence of HPV DNA in the several biological materials and if it is possible to use the saliva as screening to HPV DNA detection. The presence of tumor HPV DNA in blood may be of diagnostic and prognostic value.

NCT ID: NCT01043029 Completed - Clinical trials for Diabetes Mellitus Type 2

A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

Start date: May 2010
Phase: Phase 2
Study type: Interventional

This multi-center, randomized, double-blind, active controlled, parallel-group study in type 2 diabetes patients with moderate renal impairment will evaluate the effect on renal function and the safety and tolerability of aleglitazar compared with pioglitazone. Patients will be randomized to receive either 150 mcg aleglitazar or 45 mg pioglitazone as daily oral doses. In addition, a diet and exercise plan will also be implemented during the anticipated time on study treatment of 52 weeks. The target sample size is 200-400 patients.